Form 4: Phreesia SVP Granted 33,000 Restricted Stock Units

Phreesia's SVP of Human Resources, Amy Beth VanDuyn, was granted 33,000 Restricted Stock Units, vesting over four years.

Summary

• Amy Beth VanDuyn, SVP of Human Resources at Phreesia, Inc. (PHR), was granted 33,000 Restricted Stock Units (RSUs).
• The grant was approved by the Compensation Committee of the Board of Directors on October 1, 2025.
• Each RSU represents the contingent right to receive one share of the Issuer's common stock.
• The RSUs vest in a staggered schedule: 10% on December 5, 2026; 20% on December 5, 2027; 30% on December 5, 2028; and 40% on December 5, 2029.
• Vesting is subject to Ms. VanDuyn's continued service to Phreesia through each vesting date.
• Following this transaction, Ms. VanDuyn's beneficial ownership stands at 144,840 shares.

Sentiment

Score: 7

Explanation: The grant of RSUs is a positive signal for executive retention and alignment of interests, indicating confidence in future performance. While positive, it is a routine compensation event and not a significant market-moving catalyst on its own.

Positives

• The grant of Restricted Stock Units aligns the executive's interests with long-term shareholder value.
• The multi-year vesting schedule acts as a strong incentive for executive retention and continued service.

Risks

• The vesting of RSUs is contingent upon the reporting person's continued service to the Issuer; unvested RSUs would be forfeited if employment ceases.
• The ultimate value of the RSUs is subject to the future market price fluctuations of Phreesia's common stock.

Future Outlook

The staggered vesting schedule for the RSUs indicates a strategic approach to executive retention and aims to align the executive's long-term interests with the future performance and growth of the company.

Management Comments

• The grant of RSUs was approved by the Compensation Committee of the Board of Directors on October 1, 2025.

Industry Context

Granting Restricted Stock Units with multi-year vesting schedules is a common and standard practice in the technology and healthcare IT sectors for executive compensation. This method is widely used to incentivize long-term performance, retain key talent, and align management's financial interests with those of shareholders, consistent with practices observed in peer companies.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of executive compensation is a standard practice across the technology and healthcare IT industries, comparable to compensation structures at companies like Veeva Systems or Cerner (now Oracle Health).
• A multi-year, staggered vesting schedule, as seen with this grant, is typical for executive retention programs, ensuring long-term commitment, similar to practices at many S&P 500 companies.
• The $0 transaction price for RSUs is standard, as these awards represent a contingent right to receive shares upon meeting specific conditions (e.g., continued service), rather than an immediate purchase.

Corporate Governance

Related Party Transactions

• The RSU grant is a transaction between the company and a senior executive, which is a form of related-party transaction. However, it is a standard and transparently disclosed executive compensation practice.

Stakeholder Impact

• Shareholders: Potential future dilution upon RSU vesting, but also benefits from enhanced executive retention and alignment with long-term company performance.
• Employees: May signal stability in executive leadership and a commitment to long-term incentives for key personnel.

Next Steps

• Amy Beth VanDuyn's continued service to Phreesia to meet the vesting conditions for the RSUs.
• Automatic vesting of the RSUs on the specified dates: December 5, 2026, 2027, 2028, and 2029.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event (RSU grant) and does not contain information that would fundamentally alter the investment thesis for Phreesia. While positive for executive retention and alignment, it is not a catalyst for a 'buy' or 'sell' recommendation. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

Phreesia, PHR, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Form 4, Stock Grant, Employee Retention